As federal officials move to reclassify cannabis from a Schedule I to a Schedule III drug, University of Michigan experts say the shift could open the door to more rigorous research on a substance millions of Americans already use. The article examines why the policy change matters and why scientific evidence has struggled to keep pace with public perception.
